Beijing Leadman Biochemistry Co.,Ltd. (SHE:300289)
6.81
+0.09 (1.34%)
Apr 1, 2026, 3:04 PM CST
SHE:300289 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | 566.02 | 574.27 | 565.02 | 798.81 | 928.6 |
Trading Asset Securities | 336.75 | 316.14 | 290.29 | - | - |
Cash & Short-Term Investments | 902.77 | 890.41 | 855.32 | 798.81 | 928.6 |
Cash Growth | 1.39% | 4.10% | 7.07% | -13.98% | 163.41% |
Accounts Receivable | 92.32 | 99.02 | 149.76 | 184.48 | 232.4 |
Other Receivables | 1.75 | 19.56 | 2.4 | 6.05 | 5.67 |
Receivables | 94.07 | 118.58 | 152.16 | 190.52 | 238.08 |
Inventory | 88.72 | 89.45 | 88.28 | 97.44 | 102.48 |
Other Current Assets | 16.49 | 8.71 | 9.93 | 23.73 | 9.96 |
Total Current Assets | 1,102 | 1,107 | 1,106 | 1,111 | 1,279 |
Property, Plant & Equipment | 373.7 | 402.3 | 427.68 | 458.68 | 474.96 |
Long-Term Investments | 10.72 | 11.17 | 23.66 | 20.9 | 1.01 |
Goodwill | 73.53 | 73.53 | 144.66 | 159.54 | 190.07 |
Other Intangible Assets | 20.98 | 25.17 | 28.74 | 33.89 | 37.74 |
Long-Term Accounts Receivable | - | 1.17 | - | - | - |
Long-Term Deferred Tax Assets | 41.07 | 46.93 | 43.06 | 35.52 | 27.95 |
Long-Term Deferred Charges | 5.6 | 12.02 | 17.23 | 24.56 | 26.15 |
Other Long-Term Assets | 148.52 | 142.99 | 147.69 | 156.22 | 311.41 |
Total Assets | 1,776 | 1,822 | 1,938 | 2,000 | 2,348 |
Accounts Payable | 20.72 | 19.79 | 32.87 | 18.47 | 36.32 |
Accrued Expenses | 1.67 | 8.21 | 17.56 | 31.34 | 25.8 |
Current Portion of Long-Term Debt | 3.04 | - | - | - | - |
Current Portion of Leases | - | 4.11 | 4.29 | 3.73 | 3.31 |
Current Income Taxes Payable | 10.63 | 1.04 | 2.17 | 2 | 2.08 |
Current Unearned Revenue | 9.27 | 10.27 | 10.86 | 7.91 | 8.2 |
Other Current Liabilities | 41.41 | 37.78 | 38.63 | 89.57 | 103.49 |
Total Current Liabilities | 86.73 | 81.2 | 106.38 | 153.01 | 179.21 |
Long-Term Leases | 1.16 | 0.72 | 4.65 | 8.12 | 9.82 |
Long-Term Unearned Revenue | 14.09 | 14.57 | 15.5 | 18.32 | 19.07 |
Long-Term Deferred Tax Liabilities | 2.81 | 6.67 | 6.45 | 6.71 | 3.01 |
Other Long-Term Liabilities | 0.66 | 0.68 | 0.79 | 33.19 | 159.19 |
Total Liabilities | 105.46 | 103.84 | 133.77 | 219.35 | 370.3 |
Common Stock | 544.01 | 544.01 | 544.01 | 544.01 | 544.01 |
Additional Paid-In Capital | 610.81 | 610.81 | 610.81 | 610.81 | 651.39 |
Retained Earnings | 484.29 | 507.28 | 587.82 | 572.48 | 639.63 |
Total Common Equity | 1,639 | 1,662 | 1,743 | 1,727 | 1,835 |
Minority Interest | 31.62 | 56.48 | 61.99 | 53.16 | 143.08 |
Shareholders' Equity | 1,671 | 1,719 | 1,805 | 1,780 | 1,978 |
Total Liabilities & Equity | 1,776 | 1,822 | 1,938 | 2,000 | 2,348 |
Total Debt | 4.2 | 4.83 | 8.95 | 11.84 | 13.13 |
Net Cash (Debt) | 898.57 | 885.58 | 846.37 | 786.97 | 915.47 |
Net Cash Growth | 1.47% | 4.63% | 7.55% | -14.04% | 192.03% |
Net Cash Per Share | 1.65 | 1.63 | 1.56 | 1.40 | 2.04 |
Filing Date Shares Outstanding | 544.57 | 544.01 | 544.01 | 544.01 | 544.01 |
Total Common Shares Outstanding | 544.57 | 544.01 | 544.01 | 544.01 | 544.01 |
Working Capital | 1,015 | 1,026 | 999.3 | 957.49 | 1,100 |
Book Value Per Share | 3.01 | 3.06 | 3.20 | 3.18 | 3.37 |
Tangible Book Value | 1,545 | 1,563 | 1,569 | 1,534 | 1,607 |
Tangible Book Value Per Share | 2.84 | 2.87 | 2.88 | 2.82 | 2.95 |
Buildings | - | 486.27 | 495.09 | 488.24 | 487.72 |
Machinery | - | 281.56 | 253.19 | 245.25 | 231.03 |
Construction In Progress | - | 0.58 | 0.52 | 6.4 | - |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.